ClinicalTrials.Veeva

Menu

Genotype-related Molecular Targets in the Vitamin D Pathway for Spinal Disc Diseases (GenVDisc)

I

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Status

Unknown

Conditions

Intervertebral Disk Degeneration

Study type

Observational

Funder types

Other

Identifiers

NCT03343899
GenVDisc

Details and patient eligibility

About

The objective of our study will be to analyze the interplay between particular VDR variants and its ligand in cells obtained from intervertebral disc and cartilage endplate and their action on cell proliferation and phenotype maintenance. The identification of novel molecular targets in the vitamin D pathway, potentially promoting pathological alterations of the tissues involved in spinal disc diseases, will allow to develop innovative and more personalized preventive and pharmacological/nutritional therapies.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients with spinal disc diseases

  • males and females
  • 18≤age ≤ 70 years old
  • Italian white
  • patients with spinal disc diseases that will be surgically treated

Exclusion criteria

  • age < 18 or > 70 years old

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems